June 27, 2018

Import Compliance Risks and Opportunities for the Life Sciences Industry


Drinker Biddle’s Pharma and Life Sciences Industry Group continues to host a series of webinars designed to help our clients navigate this dynamic, regulated industry environment. Our interdisciplinary group of attorneys and professionals present on topics of interest to pharmaceutical, medical device, life sciences, health care, and biotech companies, as well as contract research organizations, research institutions, scientists, venture capitalists and investment banks.

This webinar addressed key compliance issues related to the importation of pharmaceutical products and medical devices into the United States. Among other topics, we covered:

  • Unique U.S. rules of origin for pharmaceutical products.
  • The use of available duty preference programs, such as the Prototype Provision.
  • CBP enforcement of retroactive import valuation issues related to the reporting of assists, royalties, and transfer price adjustments.

Questions? Please contact marc.kozak@faegredrinker.com


Services and Industries

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.